Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Pemetrexed EP Impurity B and Impurity C mixture, Not available
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Pemetrexed EP Impurity B and Impurity C mixture is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Pemetrexed EP Impurity B and Impurity C mixture usage and description
Pemetrexed is a chemotherapy drug that is used to treat various types of cancer, including lung cancer, mesothelioma, and non-Hodgkin's lymphoma. Pemetrexed EP Impurity B and Impurity C mixture are two impurities that may be present in the drug. These impurities may affect the efficacy and safety of the drug, and therefore, need to be monitored and controlled.
Pemetrexed EP Impurity B is an organic compound with a molecular formula of C14H19N5O6. It is a byproduct of the manufacturing process of pemetrexed and may be present in small amounts in the final product. Impurity B is a potential mutagen and may cause DNA damage. Therefore, it is important to control the levels of Impurity B in pemetrexed to ensure its safety and efficacy.
Pemetrexed EP Impurity C is another organic compound that may be present in pemetrexed. It has a molecular formula of C12H17N5O5 and is also a byproduct of the manufacturing process. Impurity C is a potential carcinogen and may cause cancer. Therefore, it is important to control the levels of Impurity C in pemetrexed to ensure patient safety.
In conclusion, Pemetrexed EP Impurity B and Impurity C mixture are two impurities that may be present in the chemotherapy drug pemetrexed. They may affect the drug's efficacy and safety, and therefore, need to be controlled and monitored.
